Metastatic Paranasal Sinus Squamous Cell Carcinoma

Explore clinical trials studying Metastatic Paranasal Sinus Squamous Cell Carcinoma. Study availability and eligibility vary by location and protocol.

2 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Metastatic Paranasal Sinus Squamous Cell Carcinoma trial results

Recruiting

Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation

NCT06662058

Conditions: Carcinoma, Carcinoma, Squamous Cell, Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +54 more
Locations: Emory Midtown University Hospital/Winship Cancer Institute Atlanta, Georgia, United States

View Trial Details

Recruiting

Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial

NCT06636734

Conditions: Carcinoma, Carcinoma, Squamous Cell, Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +43 more
Locations: Emory University Hospital Midtown Atlanta, Georgia, United States

Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States

View Trial Details

Metastatic Paranasal Sinus Squamous Cell Carcinoma

Metastatic Paranasal Sinus Squamous Cell Carcinoma trial results

Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation

Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial

Related conditions